Sex-Based Differences in Long-Term Outcomes Following Percutaneous Coronary Intervention for Chronic Total Occlusions
Ignacio Gallo1,2,3,4, Rafael Gonzalez-Manzanares1,2,3,4, Luis Carlos Maestre-Luque1,2
1Department of Cardiology, Reina Sofia University Hospital, 14002 Córdoba, Spain.
Journal of Clinical Medicine
|February 27, 2026
Summary
Sex-based differences in chronic total occlusion percutaneous coronary intervention (CTO-PCI) show similar overall outcomes but a higher risk of myocardial infarction (MI) in women. CTO-PCI is equally safe and effective for both sexes long-term.
Area of Science:
- Cardiology
- Interventional Cardiology
- Health Outcomes Research
Background:
- Sex-based differences in clinical outcomes after percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) are not well understood.
- Real-world data on long-term outcomes following CTO-PCI stratified by sex is limited.
Purpose of the Study:
- To investigate the association between sex and long-term clinical outcomes after CTO-PCI.
- To compare the safety and effectiveness of CTO-PCI in men versus women.
Main Methods:
- Retrospective analysis of 928 patients undergoing CTO-PCI (2011-2024).
- Primary endpoint: Major adverse cardiac events (MACE) at 6-year follow-up.
- Inverse Probability of Treatment Weighting (IPTW)-adjusted Cox regression used to control for baseline differences.
Main Results:
- Women were older and had higher rates of diabetes and hypertension but lower angiographic complexity.
- Technical and procedural success rates were comparable between sexes.
- Unadjusted MACE rates were higher in women, but adjusted analysis showed no significant difference in overall MACE. However, women had a significantly higher risk of myocardial infarction (MI) post-procedure.
Conclusions:
- CTO-PCI demonstrates comparable safety and effectiveness in women and men regarding overall long-term MACE.
- Despite similar overall adjusted MACE, women undergoing CTO-PCI face a significantly higher risk of myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
338
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Coronary Artery Disease V: Interprofessional Care
343
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343


